Your session is about to expire
← Back to Search
Hormone Therapy for Postpartum Depression
Study Summary
This trial is designed to study whether postpartum depression is caused by the sudden withdrawal of estrogen and progesterone.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman aged 18-50, had postpartum depression but have been well for over a year, not on medication, and have regular menstrual cycles.I am a woman aged 18-50, with past depression but well for a year, not on medication, and have regular periods.
- Group 1: Group 1, Hormone and Placebo Group
- Group 2: Group 2, Continued Replacement Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people over the age of 40 able to participate in this trial?
"The age requirement for this clinical trial are individuals who are over 18 but under 50 years of age."
How many individuals are test subjects in this clinical trial?
"Yes, the trial is still open for recruitment according to the clinicaltrials.gov website. This particular study was created on 4/26/1996 and was updated as recently as 11/4/2022. They are looking for 100 people to participate at 2 different locations."
What are the risks associated with Group 2, Continued Replacement Group for patients?
"Group 2, Continued Replacement Group, is estimated to be a 2 in terms of safety. Phase 2 trials mean that while there is some safety data, there is none yet supporting efficacy."
What is Group 2, Continued Replacement Group's primary purpose?
"The Continued Replacement Group, more colloquially known as Group 2, is most frequently used to help those who have not had a menstrual period in the last 6 months. Additionally, this group can also be used to treat conditions like hypoestrogenism, vasomotor symptoms related to menopause, and breast conditions."
What other studies have contained a Group 2, Continued Replacement Group?
"There are currently 85 clinical trials studying Group 2, Continued Replacement Group, with 16 of them in Phase 3. While some of the trials for Group 2, Continued Replacement Group are located in Cheras, Kuala Lumpur, there are 974 other locations around the world where they are taking place."
Are patient recruitment efforts ongoing for this research?
"That is correct. The clinical trial is still searching for enrollees and the listing on clinicaltrials.gov was last updated on 11/4/2022. They are looking for a total of 100 patients from 2 different medical centres."
Share this study with friends
Copy Link
Messenger